biotech · Post Traumatic Stress Disorder · Prosthetic Joint Infection · ADPT
Adaptive Biotechnologies
Adaptive Biotechnologies Corp
Adaptive Biotechnologies patent portfolio — 12 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 1165 Eastlake Ave E, Seattle, Washington 98109, US
- Founded
- 2009
- Employees
- 659
- Programs
- 19
- Drugs
- 23
- Patents
- 12
Adaptive Biotechnologies patents
12 pharmaceutical patents indexed for Adaptive Biotechnologies. 0 expire within 24 months.
Adaptive Biotechnologies has 12 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12264187
Compositions and methods for targeted therapeutic delivery to bone
granted -
US 12263179
Lyme disease-associated T cell receptor-related methods
granted -
US 12266425
T cell receptor sequences diagnostic for COVID-19 and related compositions
granted -
US 12006517
Method for purification of bacteriophage particles
granted -
US 11911345
Phage dispensing system
granted -
US 11773138
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted -
US 11390921
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
granted -
US 11192923
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted -
US 11191780
Extracellular matrix compositions for the treatment of cancer or immunological diseases
granted -
US 11041202
Method of identifying human compatible T cell receptors specific for an antigenic target
granted -
US 11026969
High affinity T cell receptors and uses thereof
granted -
US 10675303
Extracellular matrix compositions for the treatment of cancer
granted
Frequently asked questions
How many patents does Adaptive Biotechnologies have?
12 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Adaptive Biotechnologies patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.